This week, 5 Pharmaceuticals stocks are improving their overall rating on Portfolio Grader. Each of these rates an “A” (“strong buy”) or “B” overall (“buy”).
Allergan plc (AGN) boosts its rating from a C to a B this week. Allergan plc is a healthcare company focused on developing and commercializing pharmaceuticals, biologics, and medical devices. The company also gets A’s in sales growth and earnings momentum. For more information, get Portfolio Grader’s complete analysis of AGN stock.
Taro Pharmaceutical Industries Ltd. (TARO) earns a B this week, jumping up from last week’s grade of C. Taro Pharmaceutical Industries Ltd. is engaged in developing, manufacturing, and marketing prescription and over-the-counter pharmaceutical products, as well as active pharmaceutical ingredients in the United States, Canada and Israel. The company also gets A’s in return on equity and free cash flow. For more information, get Portfolio Grader’s complete analysis of TARO stock.
This week, Intellipharmaceutics International Inc.’s (IPCI) ratings are up from a C last week to a B. Intellipharmaceutics International Inc. develops drug delivery technologies. The company also gets A’s in earnings surprise. For more information, get Portfolio Grader’s complete analysis of IPCI stock.
This week, Pain Therapeutics, Inc. (PTIE) pushes up from a C to a B rating. Pain Therapeutics, Inc. develops safer or more efficacious drugs for use in pain management, particularly in the area of opioid painkillers. The company also gets A’s in earnings momentum. For more information, get Portfolio Grader’s complete analysis of PTIE stock.
Bio-Path Holdings, Inc. (BPTH) is seeing ratings go up from a C last week to a B this week. The company also gets A’s in earnings surprise. For more information, get Portfolio Grader’s complete analysis of BPTH stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
